/

Investors / Netherlands / Aglaia Oncology Funds

Aglaia Oncology Funds

Venture capital · Bilthoven, Netherlands · Europe

aglaia-oncology.comNo unsolicited pitches

Aglaia Oncology Funds invests in oncology drug development companies, selecting and maturing early-stage inventions with the potential to transform cancer treatment. The team works hands-on with portfolio companies on research and development plans, from early screening and animal feasibility studies through clinical studies, and has invested in 12 early-stage companies, 6 of which it founded.

Invests inHealthcare & Biotech

In its own wordsoncologybiotechdrug developmentlife sciencestherapeutics

Your fit with Aglaia Oncology Funds

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
7portfolio companies
0funding rounds on record
Seed to Series Astages it states
EuVECA fund registered with AFMlatest fund

Aglaia Oncology Funds lists 7 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in Netherlands. It invests most often alongside Avoro Capital Advisors, Brabant Development Agency (BOM) and Brightlands Venture Partners.

No funding round on record names Aglaia Oncology Funds yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 7 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 1 countryPortfolio size12th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach19th pct
This firmMedian of all firms
Show as a table
Aglaia Oncology Funds compared with all firms
MeasurePercentile of all firmsValue
Portfolio size12th7 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach19th1 country

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers686%
  • No longer answers00%
  • Points to another company114%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Compare Aglaia Oncology Funds head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Funds

from public registers and its site
Aglaia Oncology Fund III Coöperatieve U.A.EuVECA fund registered with AFM, ESMA register
Aglaia Oncology Growth Opportunity Fund II Coöperatieve U.A.EuVECA fund registered with AFM, ESMA register

Portfolio

7 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Cristal Delivery B.V.cristaltherapeutics.com · NetherlandsCristal Therapeutics focuses on its unique and proprietary copper free click chemistry CliCr
Healthcare & Biotech
Portfolio page
Merusmerus.nl
Healthcare & Biotech
Portfolio page
MIMETASmimetas.comMIMETAS creates human tissue models for advanced drug discovery
Healthcare & Biotech
Portfolio page
Modramodrapharmaceuticals.comModra Pharmaceuticals seeks to improve the lives of cancer patients by transforming taxane treatment.
Healthcare & Biotech
Portfolio page
ORCA Therapeuticsorca-therapeutics.nl
Portfolio page
Sapreme Technologiessapreme-technologies.com · NetherlandsSapreme is a preclinical-stage biotech company developing next-generation RNA therapeutics for patients with genetically driven diseases.
Healthcare & Biotech
Portfolio page
Syntargasynthon.com
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Aglaia Oncology Funds, as last read
aglaia-oncology.com as VCinfo last read it
Site
aglaia-oncology.com
Last read
5 Nov 2026
Watching since
5 Nov 2026
Companies checked
7

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Aglaia Oncology Funds' profile as data

Pull Aglaia Oncology Funds' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/aglaia-oncology.com

# also
GET /v1/firms/aglaia-oncology.com/portfolio
GET /v1/firms/aglaia-oncology.com/coinvestors
GET /v1/firms/aglaia-oncology.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing